Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic β-cells

Toshiyuki Imasawa, Kentaro Koike, Isao Ishii, Jerold Chun, Yutaka Yatomi

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Sphingosine 1-phosphate (S1P) is a potent sphingolipid mediator that acts through five cognate G protein-coupled receptors (S1P1-S1P5) and regulates many critical biological processes. Recent studies indicated that S1P at nanomolar concentrations significantly reduces cytokine-induced apoptosis of pancreatic β-cells in which genes for S1P1-S1P4 are co-expressed. However, the S1P receptor subtype(s) involved in this effect remains to be clarified. In this study, we investigated the potential role of S1P2 in streptozotocin (STZ)-induced apoptosis of pancreatic β-cells and progression of diabetes. S1P2-deficient (S1P2-/-) mice displayed a greater survive ability, lower blood glucose levels, and smaller numbers of TUNEL-positive apoptotic β-cells to administration of a high dose of STZ than wild-type (WT) mice. S1P2-/- mice showed higher insulin/glucose ratios (an index of relative insulin deficiency) and larger insulin-positive islet areas to administration of a low dose of STZ than WT mice. Moreover, administration of JTE-013, a S1P2-specific antagonist, to WT mice ameliorated STZ-induced blood glucose elevation and reduced the incidence of diabetes. Our findings indicate that blockade of S1P2 signaling attenuates STZ-induced apoptosis of pancreatic β-cells and decreases the incidence of diabetes.

Original languageEnglish
Pages (from-to)207-211
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume392
Issue number2
DOIs
Publication statusPublished - 2010 Feb 5

Fingerprint

Lysosphingolipid Receptors
Streptozocin
Apoptosis
Medical problems
Insulin
Blood Glucose
Biological Phenomena
Sphingolipids
Incidence
In Situ Nick-End Labeling
G-Protein-Coupled Receptors
Genes
Cytokines
Glucose

Keywords

  • Blood glucose
  • Diabetes
  • Insulin
  • S1P-deficient mice
  • S1P-specific antagonist

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic β-cells. / Imasawa, Toshiyuki; Koike, Kentaro; Ishii, Isao; Chun, Jerold; Yatomi, Yutaka.

In: Biochemical and Biophysical Research Communications, Vol. 392, No. 2, 05.02.2010, p. 207-211.

Research output: Contribution to journalArticle

Imasawa, Toshiyuki ; Koike, Kentaro ; Ishii, Isao ; Chun, Jerold ; Yatomi, Yutaka. / Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic β-cells. In: Biochemical and Biophysical Research Communications. 2010 ; Vol. 392, No. 2. pp. 207-211.
@article{12551ee5498e434d9e276e74d2e44e0c,
title = "Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic β-cells",
abstract = "Sphingosine 1-phosphate (S1P) is a potent sphingolipid mediator that acts through five cognate G protein-coupled receptors (S1P1-S1P5) and regulates many critical biological processes. Recent studies indicated that S1P at nanomolar concentrations significantly reduces cytokine-induced apoptosis of pancreatic β-cells in which genes for S1P1-S1P4 are co-expressed. However, the S1P receptor subtype(s) involved in this effect remains to be clarified. In this study, we investigated the potential role of S1P2 in streptozotocin (STZ)-induced apoptosis of pancreatic β-cells and progression of diabetes. S1P2-deficient (S1P2-/-) mice displayed a greater survive ability, lower blood glucose levels, and smaller numbers of TUNEL-positive apoptotic β-cells to administration of a high dose of STZ than wild-type (WT) mice. S1P2-/- mice showed higher insulin/glucose ratios (an index of relative insulin deficiency) and larger insulin-positive islet areas to administration of a low dose of STZ than WT mice. Moreover, administration of JTE-013, a S1P2-specific antagonist, to WT mice ameliorated STZ-induced blood glucose elevation and reduced the incidence of diabetes. Our findings indicate that blockade of S1P2 signaling attenuates STZ-induced apoptosis of pancreatic β-cells and decreases the incidence of diabetes.",
keywords = "Blood glucose, Diabetes, Insulin, S1P-deficient mice, S1P-specific antagonist",
author = "Toshiyuki Imasawa and Kentaro Koike and Isao Ishii and Jerold Chun and Yutaka Yatomi",
year = "2010",
month = "2",
day = "5",
doi = "10.1016/j.bbrc.2010.01.016",
language = "English",
volume = "392",
pages = "207--211",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic β-cells

AU - Imasawa, Toshiyuki

AU - Koike, Kentaro

AU - Ishii, Isao

AU - Chun, Jerold

AU - Yatomi, Yutaka

PY - 2010/2/5

Y1 - 2010/2/5

N2 - Sphingosine 1-phosphate (S1P) is a potent sphingolipid mediator that acts through five cognate G protein-coupled receptors (S1P1-S1P5) and regulates many critical biological processes. Recent studies indicated that S1P at nanomolar concentrations significantly reduces cytokine-induced apoptosis of pancreatic β-cells in which genes for S1P1-S1P4 are co-expressed. However, the S1P receptor subtype(s) involved in this effect remains to be clarified. In this study, we investigated the potential role of S1P2 in streptozotocin (STZ)-induced apoptosis of pancreatic β-cells and progression of diabetes. S1P2-deficient (S1P2-/-) mice displayed a greater survive ability, lower blood glucose levels, and smaller numbers of TUNEL-positive apoptotic β-cells to administration of a high dose of STZ than wild-type (WT) mice. S1P2-/- mice showed higher insulin/glucose ratios (an index of relative insulin deficiency) and larger insulin-positive islet areas to administration of a low dose of STZ than WT mice. Moreover, administration of JTE-013, a S1P2-specific antagonist, to WT mice ameliorated STZ-induced blood glucose elevation and reduced the incidence of diabetes. Our findings indicate that blockade of S1P2 signaling attenuates STZ-induced apoptosis of pancreatic β-cells and decreases the incidence of diabetes.

AB - Sphingosine 1-phosphate (S1P) is a potent sphingolipid mediator that acts through five cognate G protein-coupled receptors (S1P1-S1P5) and regulates many critical biological processes. Recent studies indicated that S1P at nanomolar concentrations significantly reduces cytokine-induced apoptosis of pancreatic β-cells in which genes for S1P1-S1P4 are co-expressed. However, the S1P receptor subtype(s) involved in this effect remains to be clarified. In this study, we investigated the potential role of S1P2 in streptozotocin (STZ)-induced apoptosis of pancreatic β-cells and progression of diabetes. S1P2-deficient (S1P2-/-) mice displayed a greater survive ability, lower blood glucose levels, and smaller numbers of TUNEL-positive apoptotic β-cells to administration of a high dose of STZ than wild-type (WT) mice. S1P2-/- mice showed higher insulin/glucose ratios (an index of relative insulin deficiency) and larger insulin-positive islet areas to administration of a low dose of STZ than WT mice. Moreover, administration of JTE-013, a S1P2-specific antagonist, to WT mice ameliorated STZ-induced blood glucose elevation and reduced the incidence of diabetes. Our findings indicate that blockade of S1P2 signaling attenuates STZ-induced apoptosis of pancreatic β-cells and decreases the incidence of diabetes.

KW - Blood glucose

KW - Diabetes

KW - Insulin

KW - S1P-deficient mice

KW - S1P-specific antagonist

UR - http://www.scopus.com/inward/record.url?scp=75749105853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75749105853&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2010.01.016

DO - 10.1016/j.bbrc.2010.01.016

M3 - Article

C2 - 20060809

AN - SCOPUS:75749105853

VL - 392

SP - 207

EP - 211

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -